...
首页> 外文期刊>Pediatrics: Official Publication of the American Academy of Pediatrics >Failure to Detect Surfactant Protein-Specific Antibodies in Sera of Premature Infants Treated With Survanta, A Modified Bovine Surfactant
【24h】

Failure to Detect Surfactant Protein-Specific Antibodies in Sera of Premature Infants Treated With Survanta, A Modified Bovine Surfactant

机译:未能在经修饰的牛表面活性剂Survanta治疗的早产儿血清中检测到表面活性剂蛋白特异性抗体

获取原文
           

摘要

Serum from premature infants enrolled in either single-dose or multidose surfactant replacement studies with bovine lung-based exogenous surfactant (Survanta) were analyzed for antibodies reactive with mixtures of bovine surfactant proteins SP-B and SP-C. Sera from 404 premature infants enrolled in single-dose studies and 1024 premature infants enrolled in multidose studies were analyzed, representing a total of 987 samples and 2743 serum samples, respectively. The sera were obtained from treated and control infants at the time of treatment and 1 week, 4 weeks, and 6 months thereafter. Polyclonal antisera generated in rabbits against the small molecular weight proteins were uniformly reactive with the bovine surfactant test antigens; however, antibodies reacting with the surfactant proteins were never detected by immunoblot analysis with the infant sera. Antibodies against common human viral antigens were readily detected in infant serum samples. The horseradish-peroxidase conjugated second antibodies (antihuman immunoglobin G or antihuman immunoglobins A, G, and M) used in the studies were highly reactive with both immunoglobin G and immunoglobin M classes of human antibodies. Therefore there was failure to detect specific immunological responses to the bovine surfactant proteins present in Survanta after single or multiple doses of exogenous surfactant administered in the perinatal period.
机译:分析了参加基于牛肺基外源性表面活性剂(Survanta)的单剂量或多剂量表面活性剂替代研究的早产儿血清中与牛表面活性剂蛋白SP-B和SP-C混合物反应的抗体。分析了单剂量研究的404例早产儿和多剂量研究的1024例早产儿的血清,分别代表987份样品和2743份血清样品。在治疗时以及治疗后1周,4周和6个月从治疗和对照婴儿那里获得血清。兔产生的针对小分子蛋白质的多克隆抗血清与牛表面活性剂测试抗原具有均一反应性。然而,从未通过婴儿血清的免疫印迹分析检测到与表面活性剂蛋白反应的抗体。在婴儿血清样本中很容易检测到针对人类常见病毒抗原的抗体。研究中使用的辣根过氧化物酶偶联的第二抗体(抗人免疫球蛋白G或抗人免疫球蛋白A,G和M)与人抗体的免疫球蛋白G和免疫球蛋白M都具有高度反应性。因此,在围产期施用单剂或多剂外源性表面活性剂后,无法检测到对Survanta中存在的牛表面活性剂蛋白的特异性免疫应答。

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号